Fiche publication
Date publication
novembre 2014
Journal
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Bodini G, Savarino V, Peyrin-Biroulet L, de Cassan C, Dulbecco P, Baldissarro I, Fazio V, Giambruno E, Savarino E
Lien Pubmed
Résumé
Whether therapeutic drug monitoring of biologic therapy can predict the efficacy of adalimumab to prevent postoperative Crohn's disease recurrence is unknown.
Mots clés
Adalimumab, Anti-tumour necrosis factor alpha antibodies, Crohn's disease, Post-surgical recurrence
Référence
Dig Liver Dis. 2014 Nov;46(11):1043-6
